Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04ISG
|
||||
| Former ID |
DNC005723
|
||||
| Drug Name |
3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527801] | ||
| Formula |
C16H12ClNO
|
||||
| Canonical SMILES |
COC1=CC2=C(C=C1)C=CC(=C2Cl)C3=CN=CC=C3
|
||||
| InChI |
1S/C16H12ClNO/c1-19-13-6-4-11-5-7-14(16(17)15(11)9-13)12-3-2-8-18-10-12/h2-10H,1H3
|
||||
| InChIKey |
KRLGQBXIHBDUPS-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [527801] | |
| Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | ||
| PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
| SteroidogenesisPW000141:Steroidogenesis | |||||
| WikiPathways | Metapathway biotransformation | ||||
| Steroid Biosynthesis | |||||
| Oxidation by Cytochrome P450 | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| Glucocorticoid & Mineralcorticoid Metabolism | |||||
| Prostate Cancer | |||||
| Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
| Corticotropin-releasing hormone | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.